PTPRZ1 and ovarian carcinoma: Overexpression of PTPRZ1 enhanced the sensitivity of ovarian cancer cells to cisplatin and enhanced cell apoptosis in vitro, and inhibited tumor growth and resistance to cisplatin in vivo [63].